We are long overdue a positive announcement regarding the FDA Approval that is expected to happen here with MGON based on what was in their most recent filings. Read below to see why I think all should at the very least keep MGON on watch:
https://www.otcmarkets.com/otcapi/company/financial-report/387165/content The Company has recently announced the successful completion of its Pilot Scale-up Field Testing with its patent-pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The odor control personal hygiene products were provided to a group of incontinent human volunteers in the USA. The successful pilot project involved several hundred prototypes of adult incontinence diapers that were produced and provided to a group of incontinent human volunteers in the USA. Skin irritation testing conducted by an independent contractor according to an FDA approved protocol is underway, with results due shortly.
The Company has also recently announced the successful completion of Acute Skin Irritation Testing of its Patent-Pending Odor Control Superabsorbent Polymers (SAP) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The objective of testing was to determine skin irritation by the method of EPA OCSPP 870.2500. All procedures followed animal welfare act regulations. The material has shown no irritation in the standard protocol for acute skin irritation used for FDA submissions on medical devices. We plan to follow this up with a 50-person acute irritation study and we'll move on to a 100 subject sensitization study in humans. The Company is currently in active discussions with manufacturing and distribution partners.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.